glp 1 agonist long term side effects Do GLP-1 drugs cause cancer? New review says no, may even protect glp 1 drugs long term

First, they studied a topical eye drop of the full-length protein for an ocular-surface condition not a systemic injectable, and not the LKKTETQ fragment sold as TB-500

Carnitine in human immunodeficiency virus type 1 infection/acquired immune deficiency syndrome

With the scope expanding and more employers increasing their total annual spend providing GLP-1 coverage, employers who can get ahead of the cost trend may find themselves in a more prepared position

Here's what we've learned working with research-grade peptides: the pharmacodynamic timeline is always longer than the pharmacokinetic timeline for receptor agonists

HUBERMAN: If you're learning from and are enjoying this podcast, please subscribe to our YouTube channel